Novavax Inc.

Novavax Inc.
Stock Exchange Frankfurt Stock Exchange
EPS
-
Market Cap
-
Shares Outstanding
382.59 M
Public Float
377.64 M
Novavax Inc.
Stock Exchange NASDAQ Stock Market
EPS
$9.42
Market Cap
$120.42 M
Shares Outstanding
23.47 M
Public Float
378.41 M

Profile

Address
20 Firstfield Road
Gaithersburg Maryland 20878
United States
Employees -
Website http://www.novavax.com
Updated 09/14/2018
Novavax, Inc. operates as a clinical-stage biopharmaceutical company, which engages in the provision of development of recombinant nanoparticle vaccines and adjuvants. Its product pipeline targets infectious diseases with vaccine candidates in clinical development for respiratory syncytial virus, seasonal influenza, pandemic influenza, and Ebola virus. The company was founded in 1987 and is headquartered in Gaithersburg, MD.

Financials

View All

Stanley C. Erck
President, Chief Executive Officer & Director
John O. Marsh
Director-Emeritus